EUVIMEDEUVIMED entdecken
Leserbrief

Mitigating the cryoprecipitate shortage by using apheresis plasma as a manufacturing source

Rugved Pattarkine iD, Aida-Rae Manansala, Alyssa Ziman iD, Dawn C Ward iD

Transfusion · 2023

DOI: 10.1111/trf.17335 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Transfusion, 2023. Verfasst von Rugved Pattarkine und 3 weiteren Autor:innen. Beteiligte Einrichtung: Wing-Kwai and Alice Lee-Tsing Chung Transfusion Service, Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Lo…. Hauptthemen laut MEDLINE: Blood Component Removal. Die Arbeit nennt 3 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood Component RemovalHumansPlasmaFactor VIIIFibrinogen

Substanzen

Factor VIIIFibrinogen

Autor:innen und Institutionen

  • Wing-Kwai and Alice Lee-Tsing Chung Transfusion Service, Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.

ORCID-Profile: Rugved Pattarkine, Alyssa Ziman, Dawn C Ward

Zitieren

APA

Pattarkine, R., Manansala, A. R., Ziman, A., & Ward, D. C. (2023). Mitigating the cryoprecipitate shortage by using apheresis plasma as a manufacturing source. Transfusion. https://doi.org/10.1111/trf.17335

Vancouver

Pattarkine R, Manansala AR, Ziman A, Ward DC. Mitigating the cryoprecipitate shortage by using apheresis plasma as a manufacturing source. Transfusion. 2023. doi:10.1111/trf.17335

BibTeX
@article{Pattarkine2023,
  author = {Pattarkine, Rugved and Manansala, Aida-Rae and Ziman, Alyssa and Ward, Dawn C},
  title = {Mitigating the cryoprecipitate shortage by using apheresis plasma as a manufacturing source},
  journal = {Transfusion},
  year = {2023},
  doi = {10.1111/trf.17335}
}
Kostenlos starten →